Global drug makers face pricing pressure as China targets affordable healthcare
Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
AstraZeneca’s Imfinzi Perioperative Regimen Secures Key Backing in EU; Shares to Begin Trading in New York
MT Newswires -Shutterstock AstraZeneca (AZN.L, AZN.ST) reported two key developments on Monday: another win for Imfinzi in the…
Graham put his pain down to acid reflux then doctors told him it was cancer and he had a year to live. Now thanks to an astonishing new drug his tumour has halved and it’s helping breast cancer patients too. His doctor says: ‘It’s so exciting!’
When Graham Caveney was diagnosed with stage-four oesophageal cancer in 2022, doctors gave him just over a year…
GLP-1s, taste and what’s happening to our diets
Inside the DIY Ozempic boom Americans are cooking up their own Ozempic—here’s why that’s alarming. Jess Loren remembers…
Lower drug prices for Americans! Trump seals deal with AstraZeneca; some medicines at discounts of up to 80%
US President Donald Trump on Friday announced reaching a deal with AstraZeneca, which would lower the cost of…
50 European corporates backing startups on the path to growth, innovation, and global impact
Across Europe, big companies are becoming strong backers of startup innovation, and corporate venturing is widely used as…
Up 15% and 10% in a week! Are these 2 UK growth and income stocks about to go gangbusters?
Image source: Getty Images The pharmaceuticals sector used to be a happy hunting ground for investors looking for income…
Stocks extend September rally despite fears of US government shutdown – The Irish Times
World shares advanced on Monday, extending September’s rally in a session that finished on a note of caution…
AstraZeneca to list shares in New York while keeping London listing
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
EU Panel Recommends Tezspire for CRwNP | RT
AstraZeneca and Amgen’s Tezspire (tezepelumab) has been recommended for approval in the European Union (EU) for the treatment of adult…